These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21762813)

  • 1. Accessory mutations maintain stability in drug-resistant HIV-1 protease.
    Chang MW; Torbett BE
    J Mol Biol; 2011 Jul; 410(4):756-60. PubMed ID: 21762813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance.
    Muzammil S; Ross P; Freire E
    Biochemistry; 2003 Jan; 42(3):631-8. PubMed ID: 12534275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accessory mutations balance the marginal stability of the HIV-1 protease in drug resistance.
    Weikl TR; Hemmateenejad B
    Proteins; 2020 Mar; 88(3):476-484. PubMed ID: 31599014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced stability of monomer fold correlates with extreme drug resistance of HIV-1 protease.
    Louis JM; Tözsér J; Roche J; Matúz K; Aniana A; Sayer JM
    Biochemistry; 2013 Oct; 52(43):7678-88. PubMed ID: 24079831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decomposing the energetic impact of drug-resistant mutations: the example of HIV-1 protease-DRV binding.
    Cai Y; Schiffer C
    Methods Mol Biol; 2012; 819():551-60. PubMed ID: 22183557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inorganic polyhedral metallacarborane inhibitors of HIV protease: a new approach to overcoming antiviral resistance.
    Kozísek M; Cígler P; Lepsík M; Fanfrlík J; Rezácová P; Brynda J; Pokorná J; Plesek J; Grüner B; Grantz Sasková K; Václavíková J; Král V; Konvalinka J
    J Med Chem; 2008 Aug; 51(15):4839-43. PubMed ID: 18598016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some insights into mechanism for binding and drug resistance of wild type and I50V V82A and I84V mutations in HIV-1 protease with GRL-98065 inhibitor from molecular dynamic simulations.
    Hu GD; Zhu T; Zhang SL; Wang D; Zhang QG
    Eur J Med Chem; 2010 Jan; 45(1):227-35. PubMed ID: 19910081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.
    Lefebvre E; Schiffer CA
    AIDS Rev; 2008; 10(3):131-42. PubMed ID: 18820715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and thermodynamic basis of resistance to HIV-1 protease inhibition: implications for inhibitor design.
    Velazquez-Campoy A; Muzammil S; Ohtaka H; Schön A; Vega S; Freire E
    Curr Drug Targets Infect Disord; 2003 Dec; 3(4):311-28. PubMed ID: 14754432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the mechanism of drug resistance: X-ray structure analysis of G48V/C95F tethered HIV-1 protease dimer/saquinavir complex.
    Prashar V; Bihani SC; Das A; Rao DR; Hosur MV
    Biochem Biophys Res Commun; 2010 Jun; 396(4):1018-23. PubMed ID: 20471372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamical Network of HIV-1 Protease Mutants Reveals the Mechanism of Drug Resistance and Unhindered Activity.
    Appadurai R; Senapati S
    Biochemistry; 2016 Mar; 55(10):1529-40. PubMed ID: 26892689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural analyses of 2015-updated drug-resistant mutations in HIV-1 protease: an implication of protease inhibitor cross-resistance.
    Su CT; Ling WL; Lua WH; Haw YX; Gan SK
    BMC Bioinformatics; 2016 Dec; 17(Suppl 19):500. PubMed ID: 28155724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMC310911, a novel human immunodeficiency virus type 1 protease inhibitor, shows in vitro an improved resistance profile and higher genetic barrier to resistance compared with current protease inhibitors.
    Dierynck I; Van Marck H; Van Ginderen M; Jonckers TH; Nalam MN; Schiffer CA; Raoof A; Kraus G; Picchio G
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5723-31. PubMed ID: 21896904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of discordant HIV-1 protease resistance rankings using molecular dynamics simulations.
    Wright DW; Coveney PV
    J Chem Inf Model; 2011 Oct; 51(10):2636-49. PubMed ID: 21902276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidating a relationship between conformational sampling and drug resistance in HIV-1 protease.
    de Vera IM; Smith AN; Dancel MC; Huang X; Dunn BM; Fanucci GE
    Biochemistry; 2013 May; 52(19):3278-88. PubMed ID: 23566104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analysis of an HIV-1 protease I47A mutant resistant to the protease inhibitor lopinavir.
    Kagan RM; Shenderovich MD; Heseltine PN; Ramnarayan K
    Protein Sci; 2005 Jul; 14(7):1870-8. PubMed ID: 15937277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural studies on molecular mechanisms of Nelfinavir resistance caused by non-active site mutation V77I in HIV-1 protease.
    Gupta A; Jamal S; Goyal S; Jain R; Wahi D; Grover A
    BMC Bioinformatics; 2015; 16 Suppl 19(Suppl 19):S10. PubMed ID: 26695135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the full length HIV-1 Gag polyprotein reveals the role of its p6 subunit in viral maturation and the effect of non-cleavage site mutations in protease drug resistance.
    Su CT; Kwoh CK; Verma CS; Gan SK
    J Biomol Struct Dyn; 2018 Dec; 36(16):4366-4377. PubMed ID: 29237328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between single resistance-associated mutations in the HIV-1 protease and viral infectivity, protease activity, and inhibitor sensitivity.
    Henderson GJ; Lee SK; Irlbeck DM; Harris J; Kline M; Pollom E; Parkin N; Swanstrom R
    Antimicrob Agents Chemother; 2012 Feb; 56(2):623-33. PubMed ID: 22083488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein promiscuity: drug resistance and native functions--HIV-1 case.
    Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
    J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.